MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

UMSARS versus laryngoscopy-based assessment of dysphagia

N. El Fassi, A. Pavy-Le-Traon, E. Mouchon, O. Rascol, W. Meissner, A. Foubert-Saumier, Y. Gallois, S. Tessier, F. Ory-Magne, V. Woizard, M. Fabbri (Toulouse, France)

Meeting: 2023 International Congress

Abstract Number: 165

Keywords: Dysphagia, Multiple system atrophy(MSA): Clinical features, Multiple system atrophy(MSA): Treatment

Category: Parkinsonism, Atypical: MSA

Objective: To compare the Unified Multiple System Atrophy Rating Scale (UMSARS)   part I-item 2 with an ear/nose/throat (ENT) expert physician assessment.

Background: Early and severe pharyngo-laryngeal signs, including dysphagia and stridor, are peculiar signs of Multiple system atrophy (MSA), possibly presenting a source of major disability and a predictor of poor outcome. MSA dysphagia is routinely assessed by the UMSARS part I-item 2.

Method: We retrospectively analyzed the data of MSA patients who underwent an ENT assessment (nasofibroscopic and radioscopic exam) and an annual UMSARS assessment. Deglutition Handicap Index (DHI) and pulmonary/nutrition complications were collected.

Results: Seventy-five MSA patients were included. Overall, patients had a mean (SD) age of 63.49 (7.56) years and a mean (SD) disease duration of 4.17 (2.35) years at the time of neurological/ENT assessment. According to the UMSARS “swallowing” item patients were classified as follows: 18 (24%) at level 1, 35 (46.6%) at level 2, 17 (22.6%) at level 3 and 5 (0.6%) level 4 with nasogastric tube or gastrostomy feeding (Table 1). The ENT assessment revealed more severe dysphagia compared to the UMSARS part I-item 2 score (p=0.003) (Figure 1). A higher proportion of patients with impaired protective mechanisms showed severe UMSARS-based dysphagia (p=0.005). Patients with choking and oral/pharyngeal transit defects and nutritional complications were equally distributed across UMSARS part I-item 2 scores. Worse UMSARS part I-item 2 scores had worse DHI scores.

Conclusion: The UMSARS-based assessment of dysphagia does not capture key aspects of pharyngo-laryngeal dysfunction reflecting swallowing efficiency. However, the early detection of these impairments by an ENT assessment may more efficiently allow the implementation of strategies to prevent malnutrition and aspiration pneumonia.

Table 1

Figure 1

To cite this abstract in AMA style:

N. El Fassi, A. Pavy-Le-Traon, E. Mouchon, O. Rascol, W. Meissner, A. Foubert-Saumier, Y. Gallois, S. Tessier, F. Ory-Magne, V. Woizard, M. Fabbri. UMSARS versus laryngoscopy-based assessment of dysphagia [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/umsars-versus-laryngoscopy-based-assessment-of-dysphagia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/umsars-versus-laryngoscopy-based-assessment-of-dysphagia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley